Athira Pharma Stock In The News
| ATHA Stock | USD 0.63 0.01 1.56% |
Our overall analysis of Athira Pharma's news coverage and content from conventional and social sources shows investors' bearish mood towards Athira Pharma. The specific impact of Athira Pharma news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Athira Pharma's overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Athira Pharma headlines in addition to utilizing other, more conventional financial analysis modules. Check out Athira Pharma Backtesting and Athira Pharma Hype Analysis. For information on how to trade Athira Stock refer to our How to Trade Athira Stock guide.
Athira |
Athira Pharma Today Top News and Investor Outlook
Athira Pharma Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Athira and other traded companies coverage with news coverage. We help investors stay connected with Athira headlines for the 26th of November to make an informed investment decision based on correlating the impacts of news items on Athira Stock performance. Please note that trading solely based on the Athira Pharma hype is not for everyone as timely availability and quick action are needed to avoid losses.
Athira Pharma stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Athira earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Athira Pharma that are available to investors today. That information is available publicly through Athira media outlets and privately through word of mouth or via Athira internal channels. However, regardless of the origin, that massive amount of Athira data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Athira Pharma news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Athira Pharma relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Athira Pharma's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Athira Pharma alpha.
Athira Largest EPS Surprises
Earnings surprises can significantly impact Athira Pharma's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2021-08-16 | 2021-06-30 | -0.34 | -0.38 | -0.04 | 11 | ||
2021-05-13 | 2021-03-31 | -0.3 | -0.25 | 0.05 | 16 | ||
2021-11-10 | 2021-09-30 | -0.5 | -0.42 | 0.08 | 16 | ||
2022-03-24 | 2021-12-31 | -0.54 | -0.45 | 0.09 | 16 | ||
2024-05-15 | 2024-03-31 | -0.79 | -0.69 | 0.1 | 12 | ||
2022-11-10 | 2022-09-30 | -0.63 | -0.53 | 0.1 | 15 |
Athira Pharma Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Athira Pharma Stock. Current markets are strongly bearish. About 75% of major world exchanges and indexes are down. See today's market update for more information.
7th of November 2024
Athira Pharma Reports Third Quarter 2024 Financial Results and Pipeline and Business Updat... at finance.yahoo.com
22nd of October 2024
Athira Pharma to Present Results from Phase 23 LIFT-AD Clinical Trial of Fosgonimeton at t... at finance.yahoo.com
10th of October 2024
ATHA Energy Corp TD Securities Annual Nuclear Fuel Cycle and Next Generation Nuclear Round... at accesswire.com
1st of October 2024
Insider Trading at MacroaxisInsider
19th of September 2024
ATHA Energy Expands Angilak Project by Acquiring Entire Prospective Corridor at finance.yahoo.com
5th of September 2024
Disposition of 5032 shares by Litton Mark James of Athira Pharma at 0.566 subject to Rule ... at MacroaxisInsider
4th of September 2024
Athira stock plunges on Alzheimers trial setback at seekingalpha.com
3rd of September 2024
Acquisition by Litton Mark James of 20000 shares of Athira Pharma subject to Rule 16b-3 at seekingalpha.com
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Athira Pharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Athira Pharma's short interest history, or implied volatility extrapolated from Athira Pharma options trading.
Check out Athira Pharma Backtesting and Athira Pharma Hype Analysis. For information on how to trade Athira Stock refer to our How to Trade Athira Stock guide.You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Athira Pharma. If investors know Athira will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Athira Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.78) | Return On Assets (0.48) | Return On Equity (0.85) |
The market value of Athira Pharma is measured differently than its book value, which is the value of Athira that is recorded on the company's balance sheet. Investors also form their own opinion of Athira Pharma's value that differs from its market value or its book value, called intrinsic value, which is Athira Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Athira Pharma's market value can be influenced by many factors that don't directly affect Athira Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Athira Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Athira Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Athira Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.